Liqi Bi

856 total citations
29 papers, 468 citations indexed

About

Liqi Bi is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Liqi Bi has authored 29 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 13 papers in Immunology and 7 papers in Hematology. Recurrent topics in Liqi Bi's work include Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Liqi Bi is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Liqi Bi collaborates with scholars based in China and United States. Liqi Bi's co-authors include Jun Wei, Ping Li, Song Ding, Xuetong Wang, Lijun Wu, Xin Zhang, Xiaofeng Zeng, Jiuliang Zhao, Xiaoxia Zuo and Tianjiao Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomedicine & Pharmacotherapy and Journal of Cellular and Molecular Medicine.

In The Last Decade

Liqi Bi

28 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqi Bi China 16 259 184 108 71 51 29 468
Silvia Bilia Italy 4 265 1.0× 112 0.6× 148 1.4× 79 1.1× 49 1.0× 8 495
Riccardo Terenzi Italy 11 186 0.7× 134 0.7× 91 0.8× 45 0.6× 52 1.0× 23 393
Eiji Torikai Japan 13 216 0.8× 190 1.0× 80 0.7× 76 1.1× 33 0.6× 24 463
Zhimin Lu China 12 192 0.7× 233 1.3× 98 0.9× 68 1.0× 44 0.9× 21 454
B. W. Kirkham Australia 11 263 1.0× 135 0.7× 93 0.9× 77 1.1× 27 0.5× 16 487
Elisa Gómez Spain 9 329 1.3× 231 1.3× 74 0.7× 125 1.8× 48 0.9× 14 602
Emily Littlejohn United States 7 202 0.8× 102 0.6× 73 0.7× 32 0.5× 27 0.5× 14 357
F. Figus Italy 7 274 1.1× 69 0.4× 54 0.5× 43 0.6× 53 1.0× 11 400
Kasper Fjellhaugen Hjuler Denmark 14 175 0.7× 386 2.1× 55 0.5× 48 0.7× 58 1.1× 20 548
Xiangcong Zhao China 12 126 0.5× 186 1.0× 89 0.8× 53 0.7× 49 1.0× 37 413

Countries citing papers authored by Liqi Bi

Since Specialization
Citations

This map shows the geographic impact of Liqi Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqi Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqi Bi more than expected).

Fields of papers citing papers by Liqi Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqi Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqi Bi. The network helps show where Liqi Bi may publish in the future.

Co-authorship network of co-authors of Liqi Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Liqi Bi. A scholar is included among the top collaborators of Liqi Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqi Bi. Liqi Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Liqi, et al.. (2024). Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis. Biomedicine & Pharmacotherapy. 174. 116551–116551. 4 indexed citations
2.
Li, Zhe, et al.. (2023). New insights into MAIT cells in autoimmune diseases. Biomedicine & Pharmacotherapy. 159. 114250–114250. 15 indexed citations
3.
Zhao, Dongbao, Dongyi He, Liqi Bi, et al.. (2021). Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial. Rheumatology and Therapy. 8(1). 361–374. 4 indexed citations
4.
Bi, Liqi, et al.. (2020). Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis. Clinical Rheumatology. 39(9). 2653–2661. 20 indexed citations
5.
6.
7.
8.
Li, Qiuxia, Li Li, Liqi Bi, et al.. (2016). Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial. Trials. 17(1). 337–337. 17 indexed citations
9.
An, Yuan, Tian Liu, Dongyi He, et al.. (2016). The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study. Clinical Rheumatology. 36(1). 35–43. 32 indexed citations
10.
Ye, Hua, Yin Su, Ru Li, et al.. (2016). Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort. Clinical Rheumatology. 35(10). 2397–2401. 7 indexed citations
11.
12.
13.
14.
Li, Ping, et al.. (2015). Predictors of response to TNF-α antagonist therapy in Chinese rheumatoid arthritis. Clinical Rheumatology. 34(7). 1203–1210. 23 indexed citations
15.
Li, Ping, et al.. (2015). Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy.. PubMed. 8(5). 7809–15. 31 indexed citations
16.
Lv, Bin, et al.. (2015). CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice. Acta Histochemica. 117(8). 732–737. 22 indexed citations
17.
Zhang, Shangzhu, Jinmei Su, X Li, et al.. (2015). Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus. Lupus. 24(12). 1267–1275. 23 indexed citations
18.
Tian, Xinping, Mengtao Li, Zhizhong Ye, et al.. (2014). Related factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV. International Journal of Rheumatic Diseases. 18(6). 654–660. 16 indexed citations
19.
Domizio, Jérémy Di, Stephanie Dorta‐Estremera, Mihai Gagea, et al.. (2012). Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity. Proceedings of the National Academy of Sciences. 109(36). 14550–14555. 46 indexed citations
20.
Ding, Song, et al.. (2010). [Evaluation of MRI in the diagnosis of rheumatoid arthritis].. PubMed. 90(43). 3049–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Bilia Breakdown of academic impact, for papers by Riccardo Terenzi Breakdown of academic impact, for papers by Eiji Torikai Breakdown of academic impact, for papers by Zhimin Lu Breakdown of academic impact, for papers by B. W. Kirkham Breakdown of academic impact, for papers by Elisa Gómez Breakdown of academic impact, for papers by Emily Littlejohn Breakdown of academic impact, for papers by F. Figus Breakdown of academic impact, for papers by Kasper Fjellhaugen Hjuler Breakdown of academic impact, for papers by Xiangcong Zhao
Rankless by CCL
2026